Analysen von Trung Huynh

29.04.25 Pfizer Neutral UBS AG
14.04.25 Pfizer Neutral UBS AG
05.02.25 Pfizer Neutral UBS AG
04.02.25 Pfizer Neutral UBS AG
19.12.24 Pfizer Neutral UBS AG
17.12.24 Pfizer Neutral UBS AG
14.11.24 Pfizer Neutral UBS AG
01.11.24 Pfizer Neutral UBS AG
31.07.24 Pfizer Neutral UBS AG
01.05.24 Pfizer Neutral UBS AG
31.01.24 Pfizer Neutral UBS AG
30.01.24 Pfizer Neutral UBS AG
14.12.23 Pfizer Neutral UBS AG
01.12.23 Pfizer Neutral UBS AG
01.11.23 Pfizer Neutral UBS AG
31.10.23 Pfizer Neutral UBS AG
21.10.23 Pfizer Neutral UBS AG
02.08.23 Pfizer Neutral Credit Suisse Group
12.07.23 Pfizer Neutral Credit Suisse Group
29.06.23 Pfizer Neutral Credit Suisse Group
03.05.23 Pfizer Outperform Credit Suisse Group
14.04.23 Pfizer Outperform Credit Suisse Group
18.01.23 Pfizer Outperform Credit Suisse Group
13.12.22 Pfizer Outperform Credit Suisse Group
06.12.22 Pfizer Outperform Credit Suisse Group
23.11.22 Pfizer Outperform Credit Suisse Group
14.05.21 Merck Outperform Credit Suisse Group
13.05.21 Merck Outperform Credit Suisse Group
13.05.21 Bayer Neutral Credit Suisse Group
06.05.21 Novo Nordisk Neutral Credit Suisse Group
04.05.21 AstraZeneca Outperform Credit Suisse Group
03.05.21 AstraZeneca Outperform Credit Suisse Group
29.04.21 GSK Underperform Credit Suisse Group
29.04.21 Sanofi Outperform Credit Suisse Group
28.04.21 Novartis Neutral Credit Suisse Group
22.04.21 Roche Neutral Credit Suisse Group
22.04.21 Roche Neutral Credit Suisse Group
15.04.21 GSK Underperform Credit Suisse Group
08.04.21 AstraZeneca Outperform Credit Suisse Group
07.04.21 AstraZeneca Outperform Credit Suisse Group
31.03.21 Sanofi Outperform Credit Suisse Group
05.03.21 Merck Outperform Credit Suisse Group
26.02.21 Bayer Neutral Credit Suisse Group
12.02.21 AstraZeneca Outperform Credit Suisse Group
08.02.21 Sanofi Outperform Credit Suisse Group
05.02.21 Roche Neutral Credit Suisse Group
04.02.21 Novo Nordisk Neutral Credit Suisse Group
04.02.21 GSK Underperform Credit Suisse Group
27.01.21 Novartis Neutral Credit Suisse Group
20.01.21 Merck Outperform Credit Suisse Group